All Updates

All Updates

icon
Filter
Funding
PatSnap raises USD 300 million in Series E financing
AI Drug Discovery
Mar 16, 2021
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Mar 16, 2021

PatSnap raises USD 300 million in Series E financing

Funding

  • PatSnap, an AI patent intelligence platform based between Singapore and the UK, has raised USD 300 million in a Series E funding round led by SoftBank Vision Fund 2 and Tencent Investment, with participation from CITIC Industrial Fund, Sequoia China, and Vertex Ventures. This brings the company’s total funds raised to USD 351.6 million, with its valuation reportedly crossing USD 1 billion. 

  • The proceeds will be used to further develop the company’s intelligence platform, accelerate software product development, and expand the global sales team. 

  • Founded in 2007, PatSnap operates a software platform that uses AI to combine millions of data points from patents, licensing, litigation, and other sources to provide intelligence that helps companies streamline R&D. The company’s products can be used across various sectors and its life science-focused product, PatSnap Bio, allows pharmaceutical companies to search for protein, DNA, and RNA sequences within patent and non-patent sources to improve their R&D process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.